Jeffrey M Gelfand
Affiliation: University of California
- Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentationJeffrey M Gelfand
Department of Neurology, University of California, San Francisco, USA Electronic address
Handb Clin Neurol 122:269-90. 2014....
- Microcystic inner nuclear layer abnormalities and neuromyelitis opticaJeffrey M Gelfand
Multiple Sclerosis Center, Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA
JAMA Neurol 70:629-33. 2013..Acute optic neuritis is a cardinal manifestation of neuromyelitis optica (NMO). To our knowledge, microcystic inner nuclear layer abnormalities have not been investigated in NMO...
- Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple SclerosisRegina Schlaeger
Department of Neurology, University of California, San Francisco2Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland
JAMA Neurol 72:897-904. 2015..The corresponding relationships in the thoracic cord are unknown owing to technical difficulties in assessing GM and WM compartments by conventional magnetic resonance imaging techniques...
- Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypesJeffrey M Gelfand
University of California, San Francisco Department of Neurology, Multiple Sclerosis Center, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 7:e36847. 2012....
- Fingolimod treatment in multiple sclerosis leads to increased macular volumeRachel Nolan
Multiple Sclerosis Center, UCSF Department of Neurology, San Francisco, CA, USA
Neurology 80:139-44. 2013..To determine whether fingolimod, an oral sphingosine-1-phosphate receptor modulator approved for treatment of multiple sclerosis (MS), generally leads to increased retinal tissue volume...
- Microcystic macular oedema in multiple sclerosis is associated with disease severityJeffrey M Gelfand
Multiple Sclerosis Centre, University of California, San Francisco, Department of Neurology, 400 Parnassus Ave, San Francisco, CA 94143 0114, USA
Brain 135:1786-93. 2012..These findings also have implications for clinical monitoring in patients with multiple sclerosis on sphingosine 1-phosphate receptor modulating agents...
- Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyShiv Saidha
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Lancet Neurol 11:963-72. 2012..We aimed to determine whether MMO of the INL, and increased thickness of the INL are associated with disease activity or disability progression...
- Spinal cord gray matter atrophy correlates with multiple sclerosis disabilityRegina Schlaeger
Department of Neurology, University of California, San Francisco, San Francisco, CA Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland
Ann Neurol 76:568-80. 2014..Using phase-sensitive inversion recovery (PSIR) magnetic resonance imaging, we determined the association of the SC GM and SC WM areas with MS disability and disease type...
- Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challengeJeffrey M Gelfand
Multiple Sclerosis and Neuroinflammation Center, Department of Neurology, University of California, San Francisco
JAMA Neurol 72:66-72. 2015..Such cases are generally referred to pathologically as encephalitis, not otherwise specified (ENOS). A systematic approach to diagnostic evaluation in such patients is challenging, and currently there is no generally accepted algorithm...